• 1
    Brookes SM, Nunez A, Choudhury B et al. Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs. PLoS ONE 2010; 5:e9068.
  • 2
    Pasma T, Joseph T. Pandemic (H1N1) 2009 infection in swine herds, Manitoba, Canada. Emerg Infect Dis 2010; 16:706708.
  • 3
    Mathieu C, Moreno V, Retarnal P et al. Pandemic (H1N1) 2009 in breeding turkeys, Valparaiso, Chile. Emerg Infect Dis 2010; 16:709711.
  • 4
    Munster VJ, de Wit E, van den Brand JM et al. Pathogenesis and transmission of swine-origin 2009 A (H1N1) influenza virus in ferrets. Science 2009; 325:481483.
  • 5
    Castrucci MR, Donatelli I, Sidoli L et al. Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology 1993; 193:503506.
  • 6
    Scholtissek C, Hinshaw VS, Olsen CW. Influenza in pigs and their role as the intermediate host; in Nicholson KG, Webster RG, Hay AJ (eds): Textbook of influenza. Oxford: Blackwell Science, 1998; 137145.
  • 7
    Zhou NN, Senne DA, Landgraf JS et al. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol 1999; 73:88518856.
  • 8
    Brown IH. History and epidemiology of swine influenza in Europe. Curr Top Microbiol Immunol 2012; 370:133146.
  • 9
    Ducatez MF, Hause B, Stigger-Rosser E et al. Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerg Infect Dis 2011; 17:16241629.
  • 10
    Centers for Disease Control and Prevention (CDC). Update: influenza A (H3N2)v transmission and guidelines-five states, 2011. MMWR Morb Mortal Wkly Rep 2011; 60:17411744.
  • 11
    Vijaykrishna D, Poon LLM, Zhu HC et al. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 2010; 328:1529.
  • 12
    Zhu H, Zhou B, Fan X et al. Novel reassortment of Eurasian Avian-like and pandemic/2009 influenza viruses in swine: infectious potential for humans. J Virol 2011; 85:1043210439.
  • 13
    Vijaykrishna D, Smith GJD, Pybus OG et al. Long-term evolution and transmission dynamics of swine influenza A virus. Nature 2011; 473:519522.
  • 14
    Krumbholz A, Lange J, Durrwald R et al. Prevalence of antibodies to swine influenza viruses in humans with occupational exposure to pigs, Thuringia, Germany, 2008-2009. J Med Virol 2010; 82:16171625.
  • 15
    Perera RA, Riley S, Ma SK, Zhu HC, Guan Y, Peiris JSM. Seroconversion to pandemic (H1N1) 2009 virus and cross-reactive immunity to other swine influenza viruses. Emerg Infect Dis 2011; 17:18971899.
  • 16
    Gerloff NA, Kremer JR, Charpentier E et al. Swine influenza virus antibodies in humans, Western Europe, 2009. Emerg Infect Dis 2011; 17:403411.
  • 17
    Kyriakis CS, Olsen CW, Carman S et al. Serologic cross-reactivity with pandemic (H1N1) 2009 virus in pigs, Europe. Emerg Infect Dis 2009; 16:9699.
  • 18
    Durrwald R, Krumbholz A, Baumgarte S et al. Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity. Emerg Infect Dis 2010; 16:10291030.
  • 19
    WHO Global Influenza Surveillance Network. Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza,
  • 20
    Puzelli S, Frezza F, Fabiani C et al. Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001-02, 2002-03, and 2003-04 seasons. J Med Virol 2004; 74:629640.
  • 21
    Di Lullo G, Soprana E, Panigada M et al. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use. J Virol Methods 2010; 163:195204.
  • 22
    Brownlee GG, Fodor E. The predicted antigenicity of the hemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci 2001; 356:18711876.
  • 23
    Itoh Y, Shinya K, Kiso M et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009; 460:10211025.
  • 24
    Katz J, Hancock K, Veguilla V et al. Serum crossreactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58:521524.
  • 25
    Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:19451952.
  • 26
    Xie H, Li X, Gao J et al. Revisiting the 1976 “Swine Flu” vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice. Clin Infect Dis 2011; 53:11791187.
  • 27
    Kash JC, Qi L, Dugan VG et al. Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus. Influenza Other Respir Viruses 2010; 4:121127.
  • 28
    Vincent AL, Lager KM, Faaberg KS et al. Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza Other Respir Viruses 2010; 4:5360.
  • 29
    Manicassamy B, Medina RA, Hai R et al. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 2010; 6:e10000745.
  • 30
    Gorres JP, Lager KM, Kong WP et al. DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs. Clin Vaccine Immunol 2011; 18:19871995.
  • 31
    Min JY, Chen GL, Santos C, Lamirande EW, Matsuoka Y, Subbarao K. Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets. Virology 2010; 408:128133.
  • 32
    Greenbaum IA, Kotturi MF, Kim Y et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA 2009; 106:2036520370.
  • 33
    Xing Z, Cardona CJ. Pre-existing immunity to pandemic (H1N1) 2009. Emerg Infect Dis 2009; 15:18471849.
  • 34
    Guo H, Santiago F, Lambert K, Takimoto T, Topham DJ. T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J Virol 2011; 85:448455.
  • 35
    De Marco AM, Porru S, Cordioli P et al. Cross-reactive immunity to 2009 pandemic influenza A virus in workers seropositive to swine H1N1 influenza viruses circulating in Italy. PLoS ONE 2013; 8:e57576.
  • 36
    Busquets N, Segales J, Cordoba L et al. Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus. Vet Res 2010; 41:7486.